San Diego Business Journal

Roche Appeals to Illumina Shareholders

Wednesday, March 21, 2012

Roche Holding AG has turned to shareholders at U.S. gene-sequencing company Illumina Inc. for support, after Illumina’s board turned down Roche’s unsolicited takeover offer.

The Basel-based company said it was disappointed that the board has continued to reject its $5.7 billion cash bid and so is now appealing directly to the firm’s shareholders, urging them to tender their shares and vote for Roche’s director nominees at Illumina’s coming annual meeting on April 18.